SUSAN BORDONARO: Open Payments
NPI 1366547358 · MIDDLETOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,642 in 89 payments from 15 companies in 2025. Trend: 2023 $821 · 2024 $1,025 · 2025 $1,642
Food & beverage: $1,562Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $255 |
| Janssen Biotech, Inc. | 18 | $246 |
| LEO Pharma Inc. | 8 | $216 |
| Galderma Laboratories, L.P. | 12 | $171 |
| Amgen Inc. | 3 | $160 |
| E.R. Squibb & Sons, L.L.C. | 3 | $122 |
| Blueprint Medicines Corporation | 1 | $114 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
| GENZYME CORPORATION | 3 | $76 |
| UCB, Inc. | 3 | $71 |
Products named: TREMFYA, ADBRY, SKYRIZI, OTEZLA, DUPIXENT, Sotyktu, NEMLUVIO, Bimzelx.
Industry payments across RI — which companies pay providers there.
